November 15, 2013
Article
Bloxiverz, manufactured by Éclat Pharmaceuticals, is the first and only FDA-approved neostigmine methylsulfate injection.
September 11, 2013
July 22, 2013
This human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate is approved for the treatment of patients with HER2-positive, metastatic breast cancer.
June 18, 2013
Tecfidera (dimethyl fumarate) has been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.
May 20, 2013
This monoclonal antibody is approved to treat atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.
March 19, 2013
The carboxypeptidase is used to treat toxic plasma methotrexate concentrations in adult and pediatric patients.